Skip to main content
Equibles

ALLIANCEBERNSTEIN L.P.

Position in AKBA — Akebia Therapeutics, Inc.

CIK 1109448 NASHVILLE, TN
Back to AKBA Full portfolio

Position in AKBA

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$404,597
+$72,485 QoQ
Shares Held
354,910
+48.5% QoQ
Ownership
0.128%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#38
of 170 holders
Holding Since
Mar 2020
18 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in AKBA Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

ALLIANCEBERNSTEIN L.P. holds $485,105,474 across 44 Drug Manufacturers - Specialty & Generic names. AKBA ranks #33 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 UTHR
UNITED THERAPEUTICS Corp
 234,607 $127,117,110
2 NBIX
Neurocrine Biosciences Inc
 461,270 $77,742,445
3 RDY
Dr Reddys Laboratories Ltd
 3,730,713 $54,058,031
4 ZTS
Zoetis Inc.
 698,452 $50,190,760
5 KNSA
Kiniksa Pharmaceuticals International, plc
 556,151 $35,565,856
6 VTRS
Viatris Inc
 1,233,234 $19,583,755
7 ELAN
Elanco Animal Health Inc
 621,675 $15,299,421
8 HIMS
Hims & Hers Health, Inc.
 438,863 $15,215,380

All Filings in AKBA

Export CSV
18 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $404,597 354,910
2026-03-31 $332,112 238,930
2025-12-31 $384,677 238,930
2025-09-30 $652,278 238,930
2025-06-30 $869,705 238,930
2025-03-31 $100,358 52,270
2024-12-31 $147,516 77,640
2024-09-30 $102,484 77,640
2024-06-30 $79,192 77,640
2022-03-31 $107,940 150,335
2021-12-31 $338,175 149,635
2021-09-30 $430,948 149,635
2021-06-30 $567,116 149,635
2021-03-31 $226,236 66,835
2020-12-31 $187,138 66,835
2020-09-30 $436,755 174,006
2020-06-30 $2,421,395 178,306
2020-03-31 $930,968 122,819